CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $72,488
- in 2 filings
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,550,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Puhlmann Markus Chief Medical Officer | Purchase | +35,000 | $0.84 | $30K | 178,542 |
| 2026-11-11 | Puhlmann Markus Chief Medical Officer | Purchase | +6,000 | $0.83 | $5K | 143,542 |
| 2026-03-02 | Puhlmann Markus Chief Medical Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2025-03-03 | Puhlmann Markus Chief Medical Officer | Grant or award · Stock option (right to buy) | +165,000 | 165,000 | ||
| 2024-06-20 | Puhlmann Markus Chief Medical Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2024-01-24 | Puhlmann Markus Chief Medical Officer | Purchase | +280,000 | $0.50 | $140K | 1,375,425 |
| 2023-12-19 | Puhlmann Markus Chief Medical Officer | Purchase | +400,000 | $0.34 | $137K | 1,095,425 |
| 2023-12-18 | Puhlmann Markus Chief Medical Officer | Purchase | +60,419 | $0.26 | $15K | 695,425 |
| 2023-12-15 | Puhlmann Markus Chief Medical Officer | Purchase | +135,006 | $0.27 | $36K | 635,006 |
| 2023-12-12 | Puhlmann Markus Chief Medical Officer | Grant or award · Stock Options (right to buy) | +1,477,619 | 2,885,688 |
Page 1 of 1 · 10 trades